Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002956
Status:
WITHDRAWN
Last Update Posted:
2016-03-21
First Post:
1999-11-01
Brief Title:
Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants
Sponsor:
University of Alabama at Birmingham
Organization:
University of Alabama at Birmingham
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| recurrent adult Hodgkin lymphoma | View |
| recurrent childhood lymphoblastic lymphoma | View |
| childhood diffuse large cell lymphoma | View |
| childhood immunoblastic large cell lymphoma | View |
| recurrentrefractory childhood Hodgkin lymphoma | View |
| T-cell large granular lymphocyte leukemia | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent adult Burkitt lymphoma | View |
| recurrent childhood small noncleaved cell lymphoma | View |
| recurrent childhood large cell lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |
| splenic marginal zone lymphoma | View |